✦ LIBER ✦

Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis

✍ Scribed by Bruno, Savino; Vierling, John M.; Esteban, Rafael; Nyberg, Lisa M.; Tanno, Hugo; Goodman, Zachary; Poordad, Fred; Bacon, Bruce; Gottesdiener, Keith; Pedicone, Lisa D.; Albrecht, Janice K.; Brass, Clifford A.; Thompson, Seth; Burroughs, Margaret H.

Book ID: 121373432
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 877 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2012.11.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of peginterferon alf

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis

Safety and efficacy of peginterferon plu

Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis

✍ F. Marrache; Y. Consigny; M. P. Ripault; D. Cazals-Hatem; M. Martinot; N. Boyer; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

255 EFFICACY AND SAFETY OF PEGUILATED IN

255 EFFICACY AND SAFETY OF PEGUILATED INTERFERON AND RIBAVIRIN IN HCV-INFECTED PATIENTS WITH ADVANCED CIRRHOSIS AWAITING LIVER TRANSPLANTATION

✍ A.C.C.A. Feldner; T.C.R. Ribeiro; M.A. Bragagnolo-Jr; J. Seda-Neto; J.D.R. Brito 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Sustained Virologic Response and Bocepre

Sustained Virologic Response and Boceprevir Resistance-Associated Variants Observed in Patients Infected With HCV Genotype 1A/1b When Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

✍ Brass, Clifford A. ;Barnard, Richard J. ;Howe, John A. ;Ogert, Robert A. ;Ralsto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 667 KB

1430 SAFETY AND EFFICACY OF BOCEPREVIR/P

1430 SAFETY AND EFFICACY OF BOCEPREVIR/PEGINTERFERON/ RIBAVIRIN (BOC/P/R) COMBINATION THERAPY FOR CHRONIC HCV G1 PATIENTS WITH COMPENSATED CIRRHOSIS: A META-ANALYSIS OF FIVE PHASE 3 CLINICAL TRIALS

✍ Vierling, J.M.; Zeuzem, S.; Poordad, F.; Bronowicki, J.-P.; Manns, M.P.; Bacon, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Efficacy and safety of Boceprevir-based

Efficacy and safety of Boceprevir-based therapy in HCVG1 treatment-experienced patients with advanced fibrosis/cirrhosis: Italian NPP survey

✍ Bruno, S.; Bollani, S.; Zignego, A.L.; Calvaruso, V.; Magni, C.; Landonio, S.; R 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB